Phase I/II Study of CAMPATH in Patients With Relapsing or Refractory Non-Hodgkin's Lymphoma

Clinical trial NCT00051701 · TERMINATED

Trial details

NCT number: NCT00051701
Sponsor: Genzyme, a Sanofi Company
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Non-Hodgkins Lymphoma

Start date: 2002-12-01
Enrollment: 61

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.